MCKENZIE JONES: Open Payments
NPI 1821193806 · LATHAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,691 in 127 payments from 16 companies in 2025. Trend: 2023 $484 · 2024 $3,058 · 2025 $2,691
Food & beverage: $2,691
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 56 | $841 |
| Janssen Biotech, Inc. | 17 | $561 |
| Novartis Pharmaceuticals Corporation | 17 | $286 |
| Incyte Corporation | 2 | $154 |
| UCB, Inc. | 5 | $143 |
| GENZYME CORPORATION | 4 | $121 |
| Regeneron Healthcare Solutions, Inc. | 4 | $106 |
| Galderma Laboratories, L.P. | 5 | $91 |
| Axsome Therapeutics, Inc. | 1 | $82 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
Products named: SKYRIZI, TREMFYA, COSENTYX, DUPIXENT, RINVOQ, OPZELURA, Bimzelx, Auvelity.
Industry payments across NY — which companies pay providers there.
